BillionToOne Faces Short Report Alleging Kickbacks, Flawed Diagnostic Tests
Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
Last updated: 2026-11-18 19:19:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Elevance Health, Inc. (ELV) operates in the HOSPITAL & MEDICAL SERVICE PLANS sector and is listed on NYSE. The stock is currently priced at $402.26, with a market capitalization of $96.42B and a P/E ratio of 18.24. Over the past 52 weeks, its price has ranged from $274.84 to $450.69. This page covers its latest market performance, valuation, price trends and company information.
$96.42B | |
$431.87 | |
$440.63 | |
$402.26 | |
$433.93 | |
1.12M | |
1.25M | |
18.24 | |
$450.69 | |
$274.84 | |
1.60% | |
2026-09-30 |
Elevance Health, Inc. (ELV) is currently trading at $402.26 as of 2026-11-18 19:02:55, down 6.79% ($29.44) from the previous close of $433.93
During today's regular trading session, ELV has traded between $402.26 and $440.63, with a trading volume of 1.12M shares. The current price is near the lower end of today's range.
ELV is down 1.00% during regular trading hours.
Over the past seven days, Elevance Health, Inc. (ELV) moved from $418.25 to $402.26, representing a decline of 3.82% ($15.99).
The stock traded between $402.26 and $447.42 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 1.17 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 72.5%
ELV is currently trading at $402.26, placing it 72.5% of the way from its 52-week low of $274.84 to its 52-week high of $450.69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
| Industry | HOSPITAL & MEDICAL SERVICE PLANS |
| Employees | 97,100 |
| CEO | Gail Koziara Boudreaux |
| Founded | 2001 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Elevance Health, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Dec 4, 2026 |
| Payment Date | Dec 18, 2026 |
| Dividend Per Share | $1.72 |
Latest news related to Elevance Health, Inc. and ELV stock.
Short seller Fuzzy Panda accuses BillionToOne of undisclosed Medicaid fraud, illegal kickbacks, and flawed tests in a scathing new report.
Wall Street analysts upgraded TIGO, MWH, CNX, TNDM and ELV, with mixed price-target changes.
Argus Research analyst David Toung upgrades Elevance Health (NYSE:ELV) from Hold to Buy and announces $510 price target.
Federal regulators propose sweeping Medicare, Medicaid, and Marketplace anti-fraud reforms projected to save taxpayers nearly $90 billion.
The Centers for Medicare & Medicaid Services (CMS) today issued a proposed rule that could save taxpayers nearly $90 billion over the next 10 years and would strengthen program integrity (PI) oversight and the
Eligible investors can buy real shares of Elevance Health, Inc. (ELV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ELV, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ELV shares and USD.
ELV Shares to USD
1.00 ELV shares = 402.258 USD
Calculations are estimates based on the latest available price and are for reference only.